ALCOPOD CV Tablet is a powerful broad-spectrum antibiotic formulated with Cefpodoxime Proxetil (a third-generation cephalosporin antibiotic) and Potassium Clavulanate (a beta-lactamase inhibitor). This combination is designed to effectively combat bacterial infections, including those caused by drug-resistant strains.

• Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial death. It is effective against a wide range of gram-positive and gram-negative bacteria and is commonly prescribed for respiratory tract infections, urinary tract infections (UTIs), skin infections, and ENT (ear, nose, throat) infections.

• Potassium Clavulanate enhances the effectiveness of Cefpodoxime by inhibiting beta-lactamase enzymes, which are produced by certain bacteria to resist antibiotics. This ensures that the antibiotic remains active against resistant pathogens.

Together, this combination provides enhanced protection and a faster resolution of infections, making it ideal for more complicated or recurring bacterial infections.